The LEADER trial (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide) studies showed no significant increase in pancreatitis rates compared to placebo
Accessed July 1, 2025.
Lau DCW, Erichsen L, Francisco AM et al (2021) Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
Lucie achieve real, sustainable weight loss
Enhanced Muscle Mass: The combination of Tesamorelin Ipamorelin peptide stack could significantly enhance muscle mass by stimulating growth hormone (GH) release and increasing insulin-like growth factor 1 (IGF-1) levels
BPC-157 in the context of tissue regeneration Beyond the digestive system, BPC-157 is also widely discussed in the context of tissue regeneration